TMCI Earnings

Quarterly EPS
$-0.25
Q3 2024
$-0.01
Q4 2024
$-0.25
Q1 2025
$-0.28
Q2 2025
$-0.26
Q3 2025
$-0.15
Q4 2025
$-0.28
Q1 2026
$-0.24
Q2 2026
Latest Revenue45.4M
Latest Net Income-15873000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.2445.4M-15873000-4.2%+14.3%
Q1 2026-$0.2847.2M-17961000-10.2%-12.0%
Q4 2025-$0.1562.5M-9394000-9.0%-1,400.0%
Q3 2025-$0.2650.2M-16288000+11.4%-4.0%
Q2 2025-$0.2847.4M-17398000+6.6%+17.6%
Q1 2025-$0.2552.6M-15922000+2.9%+16.7%
Q4 2024-$0.0168.7M-501000+10.4%+90.0%
Q3 2024-$0.2545.1M-15360000+10.6%+10.7%
Q2 2024-$0.3444.5M-21206000
Q1 2024-$0.3051.1M-18676000
Q4 2023-$0.1062.2M-6281000
Q3 2023-$0.2840.8M-17521000
Treace Medical Concepts (TMCI) — Earnings